Market Tracker

07/21 8:39am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.26
Delayed Data
As of Jul 20
 +0.16 / +1.22%
Today’s Change
8.18
Today|||52-Week Range
15.20
+34.21%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close13.10
Today’s open13.13
Day’s range13.03 - 13.51
Volume763,158
Average volume (3 months)1,204,232
Market cap$1.9B
Dividend yield--
Data as of 07/20/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-24.44%
Earnings growth (next 5 years)+13.27%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.12-0.28%
ONCESpark Therapeutics I...+1.13+1.76%
BPMCBlueprint Medicines ...+1.27+2.38%
MNTAMomenta Pharmaceutic...+0.35+2.07%
Data as of 07/20/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts